Long-lasting remission of a relapsed large cell non-Hodgkin's lymphoma by Y90 ibritumomab tiuxetan as salvage therapy

Tumori. 2009 Jan-Feb;95(1):129-30. doi: 10.1177/030089160909500125.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / radiotherapy*
  • Neoplasm Recurrence, Local / radiotherapy*
  • Radioimmunotherapy / methods*
  • Remission Induction
  • Salvage Therapy / methods*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • ibritumomab tiuxetan